Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Multiple Myeloma 124Lymphoma 71Lymphoma, Non-Hodgkin 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Leukemia, Myeloid, Acute 52Myelodysplastic Syndromes 50Neoplasms, Plasma Cell 48Hodgkin Disease 48Leukemia 42Leukemia, Lymphocytic, Chronic, B-Cell 40Lymphoma, Mantle-Cell 35Lymphoma, Large B-Cell, Diffuse 35Lymphoma, Follicular 33Burkitt Lymphoma 24Lymphoma, B-Cell, Marginal Zone 22Lymphoma, Large-Cell, Immunoblastic 21Leukemia, Myelogenous, Chronic, BCR-ABL Positive 21Myeloproliferative Disorders 20Recurrence 19Hematologic Neoplasms 19Immunoglobulin Light-chain Amyloidosis 18Leukemia, Myelomonocytic, Chronic 16Neuroblastoma 15Leukemia, Myeloid, Chronic-Phase 15Leukemia, Myeloid, Accelerated Phase 15Graft vs Host Disease 15Dendritic Cell Sarcoma, Interdigitating 15Anemia, Refractory, with Excess of Blasts 14Waldenstrom Macroglobulinemia 12Primary Myelofibrosis 12

Interventions

Rituximab 45Cyclophosphamide 34Doxorubicin 16fludarabine 14Prednisone 14Vincristine 13Etoposide 13ibrutinib 10Mycophenolic Acid 8Bortezomib 8Magnetic Resonance Spectroscopy 7Lenalidomide 7Cytarabine 7pembrolizumab 6Immunotherapy, Adoptive 6polatuzumab vedotin 5fludarabine phosphate 5Whole-Body Irradiation 5Vorinostat 5Tacrolimus 5Specimen Handling 5CT-P10 5obinutuzumab 4ibritumomab tiuxetan 4Nivolumab 4Ifosfamide 4Carmustine 4Carboplatin 4Antilymphocyte Serum 4tafasitamab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, B-Cell × Melphalan × Clear all
NCT01141712 2023-01-04

Autologous Transplant in HIV Patients (BMT CTN 0803)

Medical College of Wisconsin

Phase 2 Completed
43 enrolled 21 charts
Lymphoid

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell

NCT00992446 2020-03-18

Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Fred Hutchinson Cancer Center

Phase 2 Completed
27 enrolled 13 charts
Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT00689169 2018-03-07

ZBEAM2

Lymphoma Study Association

Phase 2 Completed
75 enrolled
Lymphoid

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡